iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Lauer Wealth LLC

Lauer Wealth LLC trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 20.8% in the third quarter, Holdings Channel reports. The firm owned 1,481 shares of the financial services provider’s stock after selling 389 shares during the period. Lauer Wealth LLC’s holdings in iShares Biotechnology ETF were worth $210,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets raised its stake in shares of iShares Biotechnology ETF by 25.7% during the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares during the period. Main Management ETF Advisors LLC lifted its holdings in iShares Biotechnology ETF by 2.6% in the 2nd quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock worth $79,451,000 after buying an additional 14,535 shares in the last quarter. Raymond James Financial Services Advisors Inc. lifted its holdings in iShares Biotechnology ETF by 24.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock worth $29,792,000 after buying an additional 42,822 shares in the last quarter. Raymond James & Associates boosted its position in iShares Biotechnology ETF by 4.4% in the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after buying an additional 7,931 shares during the last quarter. Finally, Osaic Holdings Inc. grew its stake in shares of iShares Biotechnology ETF by 9.4% during the first quarter. Osaic Holdings Inc. now owns 160,173 shares of the financial services provider’s stock valued at $21,985,000 after acquiring an additional 13,777 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 1.1 %

Shares of NASDAQ:IBB traded up $1.49 during trading on Monday, hitting $143.00. The company’s stock had a trading volume of 205,295 shares, compared to its average volume of 1,451,317. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.57. The stock’s 50-day moving average price is $145.56 and its two-hundred day moving average price is $140.09.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.